Search
IQVIA Holdings Inc
IQVAdd to Watchlist
171.220USD
+3.410+2.03%
Close 06/23, 16:00（ET）Quotes delayed by 15 min
28.58BMarket Cap
21.08P/E TTM
View Detailed Chart
TradingKey 图表Intraday
1m
30m
1h
D
W
M
D
Today
+2.03%
5 Days
-4.44%
1 Month
+1.98%
6 Months
-23.95%
Year to Date
-24.04%
1 Year
+10.34%
Key Figures
168.860Open
172.770High
1.62MVolume
21.08P/E TTM
12.04P/E Dynamic
--Dividend TTM
0.97%Turnover Ratio
167.810Prev. Close
168.860Low
137.94MTurnover
20.81P/E Static
4.59P/B
0.00%Div Yield TTM
4.87%ROA
247.04552wk High
0.78Volume Ratio
1.37BNet Profit
166.90MShares
8.1215EPS TTM
1.21Beta
22.71%ROE
136.41052wk Low
2.33%Amplitude
25.70%Gross Margin
28.58BMarket Cap
-0.02Reward/Risk
2.28%Risk Rate
TradingKey Stock Score of IQVIA Holdings Inc
Currency: USD Updated: 2026-06-23Key Insights
IQVIA Holdings Inc's fundamentals are relatively stable, and its growth potential is high.Its valuation is considered fairly valued, ranking 12 out of 389 in the Biotechnology & Medical Research industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 228.36.In the medium term, the stock price is expected to remain stable.The company has been performing well in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
IQVIA Holdings Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Negative
IQVIA Holdings Inc Highlights
StrengthsRisks
IQVIA Holdings Inc. is a global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. Its segments include Technology & Analytics Solutions, Research & Development Solutions and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides mission-critical information, technology solutions and real-world insights and services to the Company’s life science clients. The Research & Development Solutions segment primarily serves biopharmaceutical customers, and provides outsourced clinical research and clinical trial-related services. The Contract Sales & Medical Solutions segment provides healthcare provider (including contract sales) and patient engagement services to both biopharmaceutical customers and the broader healthcare market. It offers a set of strategic and implementation consulting services, including advanced analytics and commercial processes outsourcing services.
Industry Leader
The company's revenue leads the industry, with the latest annual revenue totaling USD 16.31B.
Undervalued
The company’s latest PE is 21.09, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 173.06M shares, decreasing 5.25% quarter-over-quarter.
Held by David G. Herro
Star Investor David G. Herro holds 12.56M shares of this stock.
Analyst Rating
Based on
25
analysts
Buy
Current Rating
228.356
Target Price
+36.08%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
IQVIA Holdings Inc Info
IQVIA Holdings Inc. is a global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. Its segments include Technology & Analytics Solutions, Research & Development Solutions and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides mission-critical information, technology solutions and real-world insights and services to the Company’s life science clients. The Research & Development Solutions segment primarily serves biopharmaceutical customers, and provides outsourced clinical research and clinical trial-related services. The Contract Sales & Medical Solutions segment provides healthcare provider (including contract sales) and patient engagement services to both biopharmaceutical customers and the broader healthcare market. It offers a set of strategic and implementation consulting services, including advanced analytics and commercial processes outsourcing services.
Ticker SymbolIQV
CompanyIQVIA Holdings Inc
CEOBousbib (Ari)
Websitehttps://ir.iqvia.com/
Related Instruments
+0.54%
+3.37%
+2.60%
+2.07%
+3.54%
+2.98%
+0.66%
+3.33%
+0.14%
-1.44%
+0.32%
+1.53%
+2.59%
-0.36%
+2.58%
0.00%
+0.90%
+2.77%
-5.50%
+2.33%Popular Instruments
72.334
-0.611 (-0.84%)
294.300
-2.710 (-0.91%)
200.040
-8.610 (-4.13%)
4057.630
-53.120 (-1.29%)
670.750
-61.870 (-8.45%)
1961.070
-312.660 (-13.75%)
1051.770
-159.610 (-13.18%)
346.130
-3.550 (-1.02%)
62726.060
+285.360 (+0.46%)
381.610
-23.440 (-5.79%)
FAQs
What is the current price of IQVIA Holdings Inc (IQV)?
The current price of IQVIA Holdings Inc (IQV) is 171.22.
What is the symbol of IQVIA Holdings Inc?
The ticker symbol of IQVIA Holdings Inc is IQV.
What is the 52-week high of IQVIA Holdings Inc?
The 52-week high of IQVIA Holdings Inc is 247.04.
What is the 52-week low of IQVIA Holdings Inc?
The 52-week low of IQVIA Holdings Inc is 136.41.
What is the market capitalization of IQVIA Holdings Inc?
The market capitalization of IQVIA Holdings Inc is 28.58B.
Is IQVIA Holdings Inc (IQV) currently rated as Buy, Hold, or Sell?
According to analysts, IQVIA Holdings Inc (IQV) has an overall rating of Buy, with a price target of 228.36.
What is the Earnings Per Share (EPS TTM) of IQVIA Holdings Inc (IQV)?
The Earnings Per Share (EPS TTM) of IQVIA Holdings Inc (IQV) is 7.91.
